[Mercaptoacetyltriglycine (MAG 3) 99mTc--a new radiopharmaceutic for uropoietic diagnoses].
The present authors show mercaptoacetyltrigylcine (MAG 3), labelled with 99mTc technetium, as a novel prospective diagnostic agent of the uropoietic system, replacing the injections of sodium iodohippurate labelled with 131I. The paper reports the procedure of labelling of this novel radiopharmaceutical with technetium 99mTc, evaluation of its quality by chromatographic methods, and biological distribution of MAG 3 in laboratory animals in comparison with the biodistribution of injections of sodium iodohippurate labelled with 131I.
Marosová
A
A
Klinika nukleárnej medicíny, FNsP, Martin.
Altmann
P
P
Komárek
P
P
Lepej
J
J
D000818:Animals; D006801:Humans; D009842:Oligopeptides / Q000493:pharmacokinetics; D015609:Organotechnetium Compounds / Q000493:pharmacokinetics; D011817:Rabbits; D011877:Radionuclide Imaging; D051381:Rats; D017263:Technetium Tc 99m Mertiatide; D014570:Urologic Diseases / Q000000981:diagnostic imaging*
D009842:Oligopeptides; D015609:Organotechnetium Compounds; D017263:Technetium Tc 99m Mertiatide
Merkaptoacetyltriglycín (MAG 3) 99mTc--nové rádiofarmakum v diagnostike uropoetického systému.